News|Slideshows|October 29, 2024

Medical Economics Journal

  • Medical Economics January-February 2025
  • Volume 102
  • Issue 1

Semaglutide survey: Exclusive physician results on benefits, challenges of new obesity drugs

Author(s)Grace Halsey

Doctors offer insights on the how they and their patients are using GLP-1RA medicines.

If it feels like the new antiobesity medicines are everywhere, you may not be far off.

Related to this article

Why is healthcare spending declining in 2026? ©Kuzmick - stock.adobe.com
Health care was the only one of five sectors to cut spending commitments this spring, falling 2.8% as hospitals faced rising supply costs and physicians awaited the final 2027 Medicare fee schedule, Coupa's Business Spend Index found.